Table 3.
The influence of the examined Herniaria glabra (HG-PE), H. polygama (HP-PE), and H. incana herb (HIh-PE) purified extracts on the viability of peripheral blood mononuclear cells (PBMCs). The viability of control (untreated) PBMCs was assumed as 100%; ** p < 0.01.
| The Examined Extracts | (μg/mL) | PBMCs Viability (%) | |
|---|---|---|---|
| the Resazurin-Based Assay (n = 7) | the Trypan Blue Excluding Test (n = 11) | ||
| HG-PE | 5 | 93.47 ± 6.83 | 102.73 ± 11.15 |
| 25 | 95.42 ± 6.82 | 97.49 ± 8.25 | |
| 50 | 93.82 ± 12.51 | 89.22 ± 14.37 | |
| HP-PE | 5 | 93.11 ± 10.27 | 99.06 ± 11.36 |
| 25 | 95.17 ± 8.46 | 97.83 ± 10.97 | |
| 50 | 68.49 ± 17.29 ** | 87.69 ± 12.08 | |
| HIh-PE | 5 | 93.52 ± 10.47 | 101.18 ± 13.86 |
| 25 | 96.85 ± 9.89 | 101.76 ± 13.29 | |
| 50 | 99.98 ± 13.60 | 92.84 ± 14.54 | |